Hollister Biosciences Inc. (HOLL.CN)
| Previous Close | 0.2300 |
| Open | 0.2350 |
| Bid | 0.2150 x N/A |
| Ask | 0.2200 x N/A |
| Day's Range | 0.2150 - 0.2350 |
| 52 Week Range | 0.1150 - 0.5300 |
| Volume | 58,200 |
| Avg. Volume | 159,389 |
| Market Cap | 58.024M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 43.00 |
| EPS (TTM) | 0.0050 |
| Earnings Date | Nov. 29, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- CNW Group
Hollister Biosciences Inc. Announces Results of Its 2021 Annual General and Special Shareholder Meeting
Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the "Company" or "Hollister Biosciences") today announced results of its 2021 Annual General and Special Shareholder Meeting (the "Meeting") held on November 22, 2021.
- CNW Group
Hollister Biosciences Inc. to Report Q3 2021 Financial Results on November 29, 2021
Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the "Company", "Hollister Cannabis Co." or "Hollister") today announced it will release its third quarter fiscal year ended September 30, 2021 after market close on Monday, November 29, 2021.
- CNW Group
Hollister Announces Receipt of Decision from Ontario Securities Commission
Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the "Company", "Hollister Cannabis Co." or "Hollister") is pleased to announce that in connection with its upcoming annual general and special meeting of shareholders (the "AGM"), the Company has received an order from the Ontario Securities Commission granting Hollister an exemption from certain provisions governing disclosure and other matters applicable to issuers with outstanding "restricted securities".
